From trial data: mRNA shots definitely associated with excess risk of serious adverse events

In August 2022, a paper was published showing the results of secondary analysis of serious adverse events reported in the placebo-controlled, phase III randomized clinical trials of Pfizer and Moderna mRNA COVID-19 vaccines in adults.

The results?

In the Pfizer trial, for every 10,000 vaccinated there were 10.1 more serious adverse events, over the placebo baseline of 17.6 (52 total serious AESI in the jabbed group versus 33 in the placebo).

In the Moderna trial, it was 15.1 more than the placebo baseline of 42.2 epr 10,000 (87 total serious AESI in the jabbed group versus 64 in the placebo).

That translates to the Pfizer trial exhibiting a 36 % higher risk and the Moderna trial exhibiting a 6 % higher risk of serious adverse events in mRNA vaccine recipients than in the placebo group

Combined, the mRNA vaccines were associated with an excess risk of serious adverse events of special interest of 12.5 per 10,000 vaccinated.

12.5 per 10,000 is 1.25 per 1,000 and 1 serious adverse event per 800 people vaccinated with an mRNA shot.

How does that compare to other vaccines?

Swine flu vaccine, 1976

1 serious event per 1,000 vacinees = lower risk than the COVID mRNA shots

(Numbers suffering Guillain Barre syndrome were particularly high)

Withdrawn

Rotavirus vaccine (Rotashield) 1999

1-2 serious events per 10,000 vacinees = lower risk than the COVID mRNA shots

Withdrawn

COVID-19 mRNA vaccines

1 serious event per 800 vaccinees

Officially promoted

So, why haven't the COVID jabs been withdrawn? Good question.

As per the conclusion of the paper: what's now required is for Pfizer and Moderna to release their participant data, so that proper risk/benefit anyalysis can be done, according to age and sex.

Watch Dr John Campbell's 15 min video on this:

Published 30th Dec 2022

And a video statement posted on 9th January by Dr Joseph Fraiman, one of the authors of the paper, which is now peer reviewed in the journal, Vaccine: